| Autor: |
Dan G. Duda, Rakesh K. Jain, David P. Ryan, Charles S. Fuchs, Michelle Knowles, Eamala Vasudev, Eileen Regan, Susan Sheehan, Alona Muzikansky, Pankaj Bhargava, Nadine Jackson McCleary, Thomas A. Abrams, Jeffrey A. Meyerhardt, Lawrence S. Blaszkowsky, Dushyant V. Sahani, Jeffrey G. Supko, Marek Ancukiewicz, Andrew X. Zhu |
| Rok vydání: |
2023 |
| Popis: |
PDF file - 159K, Supplementary Table S1: Kinetics of plasma biomarkers and circulating progenitor cells (CPCs) at days 1 and/or 14 during the first cycle of daily 30mg cediranib monotherapy in advanced HCC patients. Supplementary Table S2: Analysis of correlation between pre-treatment and on-treatment changes (normalized to baseline values) in blood biomarkers and PK parameters after daily 30mg cediranib monotherapy in advanced HCC patients. Supplementary Table S3: Analysis of correlation between adverse effects (AEs) after daily 30mg cediranib monotherapy in advanced HCC patients with pre-treatment and on-treatment changes(normalized to baseline values) in blood biomarkers. Supplementary Table S4: Changes in hemoglobin after daily 30mg cediranib monotherapy in advanced HCC patients. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
